Skip to content

Checked

Rx

PureVit DualFe Plus

ferrous fumarate, polysaccharide iron complex · PureVit DualFe Plus is a vitamin b12 (prescription) containing ferrous fumarate, polysaccharide iron complex, made by PureTek Corporation.

Type
Prescription
Drug class
Vitamin B12
Route
Oral
Manufacturers
1

PureVit DualFe Plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.

Drug facts

Generic name
ferrous fumarate, polysaccharide iron complex
Active ingredients
Calcium Pantothenate, Cupric Sulfate, Cyanocobalamin, Ferrous Fumarate, Folic Acid, Iron Dextran, Manganese Sulfate, Niacinamide, Pyridoxine Hydrochloride, Riboflavin, Sodium Ascorbate, Thiamine Mononitrate, Zinc Sulfate
Drug class
Vitamin B12
Dosage forms
Capsule
Label holder
PureTek Corporation
Label updated
01/11/2023

Uses

PureVit DualFe Plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. Also for treatment of condition in which iron deficiency and vitamin C deficiency occur together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence.

Dosage and administration

Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.

Contraindications

PureVit DualFe Plus is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

Warnings

Accidental overdose of Iron-containing products is the leading cause of fatal poisoning of children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately. Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient.

Precautions

General: Folic Acid in doses above 0.1 mg - 0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations, remain progressive. Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Geriatric Use: No clinical studies have been performed in patients age 65 and over to determine whether older patients respond differently from younger patients. Dosage should always begin at the low end of the dosage scale and should consider that elderly patients may have decreased hepatic, renal or cardiac function, and of concomitant diseases. Adverse Reactions: Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving PureVit DualFe Plus after meals may control occasional gastrointestinal disturbances. PureVit DualFe Plus is best absorbed when taken at bedtime. Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at 1-800-FDA-1088.

Side effects (adverse reactions)

Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving PureVit DualFe Plus after meals may control occasional gastrointestinal disturbances. PureVit DualFe Plus is best absorbed when taken at bedtime. Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at 1-800-FDA-1088.

Use in children

Safety and effectiveness in pediatric patients have not been established.

Use in older adults

No clinical studies have been performed in patients age 65 and over to determine whether older patients respond differently from younger patients. Dosage should always begin at the low end of the dosage scale and should consider that elderly patients may have decreased hepatic, renal or cardiac function, and of concomitant diseases.

Overdose

OVERDOSE: Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. PureVit DualFe Plus should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of reach of children. Treatment: For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.

How supplied

PureVit DualFe Plus are yellow capsules imprinted horizontally "P-112", bottles of 90 capsules NDC 59088-112-66. Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Keep in a cool, dry place.

Forms and strengths

From the FDA NDC Directory · 1 product codes

Dosage formStrengthRouteNDCs
Capsule.8 mg / 53 mg / 53 mg / 6 mg / 30 mg / 5 mg / 1 mg / 15 ug / 10 mg / 200 mg / 10 mg / 18.2 mg / 1.3 mgoral1

What pharmacies pay

National Average Drug Acquisition Cost (NADAC), week of 10/21/2026

All prices

Pharmacies paid about $0.384 per tablet, capsule or unit across 1 package code.

NADAC is a survey of what retail pharmacies pay to buy a drug. It is not the price you pay at the counter, which depends on your insurance and the pharmacy.

Side effect reports to FDA

FDA Adverse Event Reporting System (FAERS), 1 report that list ferrous fumarate, polysaccharide iron complex, data through 07/30/2026

Anyone can report a problem to FDA, and a report does not mean the drug caused the problem. Reports can be duplicated or incomplete, and counts depend on how widely a drug is used. Do not stop or change a medicine because of this list. Talk to your doctor or pharmacist.

Most often reported reactions

  • Acute kidney injury1
  • Chronic kidney disease1
  • End stage renal disease1
  • Renal tubular necrosis1

To report a side effect, use FDA MedWatch.

Manufacturers and labels

1 FDA label

  • PureTek CorporationShown hereLabel 01/11/2023 · NDC 59088-112Full label

Related recalls

FDA drug recalls that name this drug or its active ingredient

All drug recalls

PureVit DualFe Plus: common questions

What is PureVit DualFe Plus used for?
PureVit DualFe Plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.
What are the side effects of PureVit DualFe Plus?
Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. See the full side effects section on this page, and ask your doctor or pharmacist about any side effect that bothers you.
Is PureVit DualFe Plus a prescription drug?
Yes. PureVit DualFe Plus is a prescription (Rx) drug.
Are there other products with the same active ingredient as PureVit DualFe Plus?
Yes. Other FDA-listed products with the same active ingredients include Se-Tan PLUS.

Source: U.S. Food and Drug Administration, openFDA drug label (SPL) and NDC Directory · Last updated 01/11/2023 · Label text is shown as published by the manufacturer. Not medical advice